Treating asymptomatic patients with hormone-refractory prostate cancer: hormonal manipulations for the urologist

BJU Int. 2008 Mar;101(6):671-4. doi: 10.1111/j.1464-410X.2007.07336.x. Epub 2007 Dec 7.
No abstract available

Publication types

  • Review

MeSH terms

  • Androgen Antagonists / adverse effects
  • Androgen Antagonists / therapeutic use*
  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Humans
  • Male
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Prostatic Neoplasms / drug therapy*

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal